DR

Devika Rajagopalan

Active Director Director DIN 00175666
DIN 00175666 First appointment Apr 1993 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Apr 1993
Shareholding value •••• Premium profile

About Devika Rajagopalan

Data last updated:

Devika Rajagopalan is a Director at Frank Alkanes India Private Limited (since 1993), Director at Witham Synchem Coats Private Limited (since 2019) and Director at Frank Chemicals India Private Limited (since 2025). The companies operate in Chemicals, Chemicals and Materials and Manufacturing. The 3 current companies with reported revenue have a combined latest revenue of ₹1.97 Cr; the largest is Frank Alkanes India Private Limited at ₹1.49 Cr (FY 2025). Earlier, Devika Rajagopalan was a Director at Katama Biomed Private Limited (2007–2016) and Director at Hindustan Witherites Private Limited (2011–2012).

DIN 00175666
Primary Designation Director
Industry Chemicals
First Appointment 12 Apr 1993
Oldest Company Age 41 yrs
Largest company Frank Alkanes India Private Limited · ₹1.49 Cr (FY 2025)
Combined revenue ₹1.97 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Frank Alkanes India Private Limited U24222TN1993PTC024808
Director12 Apr 19931993₹1.49 Cr (FY 2025)Active
Witham Synchem Coats Private Limited U17111TN1985PTC012301
Director05 Jan 20191985₹47.9 Lakh (FY 2025)Active
Director07 Jul 20251989₹8,156 (FY 2017)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Katama Biomed Private Limited U24246TN1986PTC012760
Director29 Jan 20071986₹14.41 Cr (FY 2024)Active
Hindustan Witherites Private Limited U24294TN1991PTC020952
Director11 Apr 20111991Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Devika Rajagopalan

NameDINCompanyDesignation
Rajagopalan00175592Frank Alkanes India Private Limited , Witham Synchem Coats Private Limited and 1 moreManaging Director

Directorship timeline

Open interactive timeline →
Witham Synchem Coats Private Limited
Frank Alkanes India Private Limited
Frank Chemicals India Private Limited
Katama Biomed Private Limited
Premium access

Shareholding and investment profile for Devika Rajagopalan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devika Rajagopalan

Devika Rajagopalan currently holds 3 directorships: Frank Alkanes India Private Limited (Director, since 12 Apr 1993, revenue ₹1.49 Cr (FY 2025)); Witham Synchem Coats Private Limited (Director, since 05 Jan 2019, revenue ₹47.9 Lakh (FY 2025)); Frank Chemicals India Private Limited (Director, since 07 Jul 2025, revenue ₹8,156 (FY 2017)).

Devika Rajagopalan was first appointed on 12 Apr 1993 as Director at Frank Alkanes India Private Limited. The most recent appointment on record is 07 Jul 2025 at Frank Chemicals India Private Limited.

The 3 current companies of Devika Rajagopalan that report revenue have a combined latest revenue of ₹1.97 Cr: Frank Alkanes India Private Limited ₹1.49 Cr (FY 2025); Witham Synchem Coats Private Limited ₹47.9 Lakh (FY 2025); Frank Chemicals India Private Limited ₹8,156 (FY 2017).

Devika Rajagopalan held 2 earlier board appointments: Katama Biomed Private Limited (Director, 29 Jan 2007 to 11 Jul 2016); Hindustan Witherites Private Limited (Director, 11 Apr 2011 to 15 Oct 2012).

The current boards of Devika Rajagopalan's companies include Rajagopalan (Frank Alkanes India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available